Delivery Order SPE2DR25D1022-SPE2DR26FQS2D
Award Date 12/15/25
Potential Completion Date 12/16/25
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,894.98 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on December 10, 2025, with completion scheduled for December 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,002.50 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Feraheme 510 mg/17 mL vials. The contract, which is not set-aside and utilizes firm fixed pricing, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Feraheme 510 mg/17 mL vials valued at $2,749.40. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at $9,022.92 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on December 15, 2025. This firm fixed price, non-competitive delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,374.70 for Feraheme 510 mg/17 mL vials on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's facility...
- This federal contract award is for the delivery of Feraheme 510 mg/17 mL vials, a critical medication used in the treatment of anemia. The contract, valued at $13,118.20, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 27, 2024. This contract is not associated with any set-aside program. As a large pharmaceutical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract (SPE2DX15D1022|SPE2DX24FVEVM) by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product Feraheme (510 mg/17 ml vial) with a ceiling value of $8,234.56. The delivery order has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) awarded by DLA with a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Feraheme 510 mg/17 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $54,916.16 and a performance period extending to July 7, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract has a firm fixed-price structure and a ceiling value of $9,635.91. It was awarded on November 4, 2024, with an ultimate completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Feraheme 510 mg/17 ml vial, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The $14,952.56 contract was awarded on January 17, 2023 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of January 18, 2023 and is a firm fixed price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical...